The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery
- PMID: 6333635
- DOI: 10.1056/NEJM198411223112101
The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery
Abstract
We examined 82 patients 10 years after saphenous-vein aortocoronary bypass surgery to determine their angiographic status and to relate those findings to the risk factors for coronary-artery disease. Of 132 grafts shown to be patent 1 year after surgery, only 50 were unaffected at 10 years. The remainder were narrowed (43) or occluded (39). Disease progression in coronary arteries without grafts was also frequent, both in vessels that were normal (15 of 32) and in those with minor stenosis (25 of 53). New lesions did not develop in 15 patients, whereas they did in 67--in the grafts, the native vessels, or both. There was no significant difference between the two groups in the incidence of hypertension, diabetes, or smoking, whereas plasma levels of very-low-density lipoproteins (VLDLs) and low-density lipoproteins (LDLs) were higher, and high-density lipoprotein (HDL) levels were lower in those with new disease than in those without. Univariate analysis showed that plasma cholesterol and triglyceride levels were significantly higher at the time of surgery and at the 10-year examination in those with new lesions. Multivariate analysis indicated that among the lipoprotein indexes, levels of HDL cholesterol and plasma LDL apoprotein B best distinguished the two groups. The findings indicate that atherosclerosis in these patients was a progressive disease, frequently affecting both the grafts and the native vessels, and that the course of such disease may be related to the plasma lipoprotein levels.
Similar articles
-
[Elevated levels of plasma homocysteine related to saphenous vein graft disease after coronary artery bypass graft surgery].J Cardiol. 1998 Dec;32(6):357-62. J Cardiol. 1998. PMID: 9914952 Japanese.
-
Risk factors related to progressive narrowing in aortocoronary vein grafts studied 1 and 5 years after surgery.Circulation. 1982 Aug;66(2 Pt 2):I40-4. Circulation. 1982. PMID: 6979440
-
Late thrombosis of saphenous vein coronary bypass grafts related to risk factors.Circulation. 1988 Sep;78(3 Pt 2):I140-3. Circulation. 1988. PMID: 3261650
-
Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts.Circulation. 2004 May 4;109(17):2086-91. doi: 10.1161/01.CIR.0000127570.20508.5C. Circulation. 2004. PMID: 15123539 Review.
-
Management of dyslipidemia after coronary artery bypass grafting.Curr Opin Lipidol. 2000 Aug;11(4):369-75. doi: 10.1097/00041433-200008000-00005. Curr Opin Lipidol. 2000. PMID: 10945718 Review.
Cited by
-
Regression of coronary atherosclerosis: is it possible?Br Heart J. 1988 Feb;59(2):149-50. doi: 10.1136/hrt.59.2.149. Br Heart J. 1988. PMID: 3342156 Free PMC article. No abstract available.
-
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423].Curr Control Trials Cardiovasc Med. 2005 Oct 11;6(1):15. doi: 10.1186/1468-6708-6-15. Curr Control Trials Cardiovasc Med. 2005. PMID: 16219100 Free PMC article.
-
Alternative blood conduits: assessment of whether the porosity of synthetic prostheses is the key to long-term biofunctionality.Med Biol Eng Comput. 2000 Mar;38(2):219-25. doi: 10.1007/BF02344780. Med Biol Eng Comput. 2000. PMID: 10829417
-
Can We Pretreat Vein Grafts with Adiponectin to Improve Their Patency?Arq Bras Cardiol. 2021 Dec;117(6):1189-1190. doi: 10.36660/abc.20210902. Arq Bras Cardiol. 2021. PMID: 35613175 Free PMC article. English, Portuguese. No abstract available.
-
Why is the mammary artery so special and what protects it from atherosclerosis?Ann Cardiothorac Surg. 2013 Jul;2(4):519-26. doi: 10.3978/j.issn.2225-319X.2013.07.06. Ann Cardiothorac Surg. 2013. PMID: 23977631 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical